Literature DB >> 12662317

Neurological aspects of osteopetrosis.

C G Steward1.   

Abstract

The osteopetroses are caused by reduced activity of osteoclasts which results in defective remodelling of bone and increased bone density. They range from a devastating neurometabolic disease, through severe malignant infantile osteopetrosis (OP) to two more benign conditions principally affecting adults [autosomal dominant OP (ADO I and II)]. In many patients the disease is caused by defects in either the proton pump [the a3 subunit of vacuolar-type H(+)-ATPase, encoded by the gene variously termed ATP6i or TCIRG1] or the ClC-7 chloride channel (ClCN7 gene). These pumps are responsible for acidifying the bone surface beneath the osteoclast. Although generally thought of as bone diseases, the most serious consequences of the osteopetroses are seen in the nervous system. Cranial nerves, blood vessels and the spinal cord are compressed by either gradual occlusion or lack of growth of skull foramina. Most patients with OP have some degree of optic atrophy and many children with severe forms of autosomal recessive OP are rendered blind; optic decompression is frequently attempted to prevent the latter. Auditory, facial and trigeminal nerves may also be affected, and hydrocephalus can develop. Stenosis of both arterial supply (internal carotid and vertebral arteries) and venous drainage may occur. The least understood form of the disease is neuronopathic OP [OP and infantile neuroaxonal dystrophy, MIM (Mendelian inheritance in man) 600329] which causes rapid neurodegeneration and death within the first year. Although characterized by the finding of widespread axonal spheroids and accumulation of ceroid lipofuscin, the biochemical basis of this disease remains unknown. The neurological complications of this disease and other variants are presented in the context of the latest classification of the disease.

Entities:  

Mesh:

Year:  2003        PMID: 12662317     DOI: 10.1046/j.1365-2990.2003.00474.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  33 in total

1.  Nonlinear association between bone mineral density and all-cause mortality: the Dong-gu study.

Authors:  C K Choi; S -S Kweon; Y -H Lee; H -S Nam; K -S Park; S -Y Ryu; S -W Choi; S A Kim; M -H Shin
Journal:  Osteoporos Int       Date:  2018-07-16       Impact factor: 4.507

2.  Novel mutations of TCIRG1 cause a malignant and mild phenotype of autosomal recessive osteopetrosis (ARO) in four Chinese families.

Authors:  Xiao-Ya Zhang; Jin-Wei He; Wen-Zhen Fu; Chun Wang; Zhen-Lin Zhang
Journal:  Acta Pharmacol Sin       Date:  2017-08-17       Impact factor: 6.150

Review 3.  Endoscopic third ventriculostomy for hydrocephalus in osteopetrosis: a case report and review of the literature.

Authors:  Nobuyuki Akutsu; Junji Koyama; Atsufumi Kawamura; Tatsuya Nagashima; Masaaki Taniguchi; Eiji Kohmura
Journal:  Childs Nerv Syst       Date:  2018-01-11       Impact factor: 1.475

4.  Severe neurodegeneration with impaired autophagy mechanism triggered by ostm1 deficiency.

Authors:  Céline Héraud; Adam Griffiths; Subramanya N M Pandruvada; Manfred W Kilimann; Monica Pata; Jean Vacher
Journal:  J Biol Chem       Date:  2014-04-09       Impact factor: 5.157

5.  Endoscopic third ventriculostomy for the treatment of osteopetrosis-related hydrocephalus: a case-based update.

Authors:  Bhoresh Dhamija; Benedetta Ludovica Pettorini; Guirish Solanki
Journal:  Childs Nerv Syst       Date:  2011-05-07       Impact factor: 1.475

6.  A novel CLCN7 mutation resulting in a most severe form of autosomal recessive osteopetrosis.

Authors:  Nesrin Besbas; Markus Draaken; Michael Ludwig; Ozgur Deren; Diclehan Orhan; Yelda Bilginer; Fatih Ozaltin
Journal:  Eur J Pediatr       Date:  2009-02-24       Impact factor: 3.183

7.  Spontaneous optic nerve compression in the osteopetrotic (op/op) mouse: a novel model of myelination failure.

Authors:  Yoichi Kondo; Jenna M Ramaker; Abigail B Radcliff; Simona Baldassari; Joshua A Mayer; James N Ver Hoeve; Chuan-Li Zhang; Shing-Yan Chiu; Raymond J Colello; Ian D Duncan
Journal:  J Neurosci       Date:  2013-02-20       Impact factor: 6.167

Review 8.  Osteopetrosis.

Authors:  Zornitza Stark; Ravi Savarirayan
Journal:  Orphanet J Rare Dis       Date:  2009-02-20       Impact factor: 4.123

9.  Optic nerve compression and retinal degeneration in Tcirg1 mutant mice lacking the vacuolar-type H-ATPase a3 subunit.

Authors:  Nobuyuki Kawamura; Hiroyuki Tabata; Ge-Hong Sun-Wada; Yoh Wada
Journal:  PLoS One       Date:  2010-08-10       Impact factor: 3.240

Review 10.  Osteopetrosis: genetics, treatment and new insights into osteoclast function.

Authors:  Cristina Sobacchi; Ansgar Schulz; Fraser P Coxon; Anna Villa; Miep H Helfrich
Journal:  Nat Rev Endocrinol       Date:  2013-07-23       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.